Business Wire

TX-PURIFY-FUEL

Share
Purify Fuel’s nanO2 Combustion Catalyst® to Be Distributed in the Middle East by Kanoo Blue

Purify Fuel, Inc. (PFI), creator of the nanO2 Combustion Catalyst® that helps diesel consumers save money and reduce emissions, announced today that it has signed an exclusive distribution deal with Kanoo Blue. Purify Fuel’s nanO2 Combustion Catalyst optimizes performance and fuel efficiency in Marine Gasoil (MGO), making MGO a more cost-effective solution than Very Low Sulphur Fuel Oil (VLSFO).

Blending nanO2 Combustion Catalyst with MGO allows shipowners to avoid the compatibility issues associated with VLSFO blends and the mechanical challenges associated with running on multiple fuel types while increasing efficiency and saving money.

Further, with the recent implementation of IMO 2020’s sweeping legislation effective January 1, 2020, VLSFO prices have increased above MGO. While this trend may not hold, VLSFO pricing at/or near MGO reinforces the case for using Purify Fuel’s nanO2 Combustion Catalyst.

Through the agreement, Kanoo will act as the exclusive distribution partner in the region, helping customers in the marine, mining, oil services, transportation and power generation markets to achieve cleaner and more efficient diesel. Kanoo Blue focuses on identifying and bringing to its clients the best breakthrough technologies currently available in the world of science and technology across a wide spectrum of business segments.

“This partnership is not just good economically for the region, but it’s also great for environmental sustainability,” says Bader Abdulaziz Kanoo, Kanoo Blue Chairman. “Purify Fuel’s nanO2 Combustion Catalyst solution will help diesel engines work more efficiently while simultaneously helping to reduce harmful emissions. The timing for Purify Fuel could not be better as the region and the world search for cleaner fossil fuel options.”

“This deal builds on our first exclusive distribution partnership with Mencast Holdings, making Purify Fuel’s nanO2 Combustion Catalyst available in three of the world’s largest refueling ports — Singapore, Fujairah, and Shanghai — with annual sales of more than 20 billion gallons,” says John Carroll, CEO of Purify Fuel. “Additionally, through the efforts of our marine lead, John ‘Fozzie’ Miller, VADM (Ret), United States Navy, we are well on our way to meeting our goal of being distributed in 60% of the world’s largest ports.”

This exciting partnership will be on display at the Middle East Bunkering Convention , in Dubai. If you are a shipowner in the region and would like to learn more about how to leverage nanO2 to save money and reduce emissions, please contact us by visiting www.purifyfuel.com to schedule a meeting.

About Kanoo Blue:

Kanoo Blue was established in Bahrain for the purpose of bringing disruptive technologies to the Middle East and Africa, in the field of Energy, Nano Technology, Industrial IT, Artificial Intelligence, Bio-Technology, Water and other much needed high-end technologies to the region. Kanoo Blue is also the commercial partner for Houston Technologies, Middle-East for its portfolio of leading-edge disruptive technologies.

About Purify Fuel:

Purify Fuel creates patented nanotechnology-based rare earth oxides to help large diesel operators save money and reduce emissions. Purify Fuel’s nanO2 Combustion Catalysts® are custom blended to optimize diesel fuel and biodiesel blends for marine, fracking, military, mining, power generation, and rail markets. The combustion catalysts increase energy harvested from each gram of fuel while reducing particulate matter emissions and soot created by incomplete combustion. Purify Fuel works directly with large consumers of diesel and biodiesel fuel to help them save money, increase power, and reduce emissions.

For more information on Purify Fuel, please visit www.purifyfuel.com .

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

1NCE Continues Growth and Expands Its Software, AI and Services Offering7.1.2026 14:15:00 CET | Press release

In 2025 1NCE added another 10 million endpoints to its foundational IoT platform; now manages 40+ million intelligent products for 30,000 customers in 17 industries. Introduces new software, 1NCE Insights, the AI + IoT fusion of intelligence from its network that gives analytics and benchmark data on how customers can better setup, manage and optimize their device estates. 1NCE, a company offering a plug-and-play platform for creating and managing the world’s best IoT products, reports another strong growth year, adding another 10 million endpoints. The company now manages 40+ million intelligent products for 30,000+ customers across 17 industries. 1NCE’s software and connectivity platform has become a new industry standard, delivering hassle-free IoT in 170+ countries and regions. The company has a unique vantage point in the IoT ecosystem, with four billion data records per day collected through 250+ streams on the world’s largest IoT network in the cloud. The company launched a new

Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking7.1.2026 14:00:00 CET | Press release

Prudentia Sciences, a pioneer in AI-native due diligence for life sciences dealmaking, today announced that it has secured $20 million in Series A financing. The round was led by McKesson Ventures with participation from SignalFire. Existing investors include Iaso Ventures, Virtue and GV. This brings the company’s total funding to $27 million, following a $7 million seed round in 2024. Prudentia Sciences provides an AI-native platform that enables pharma companies, biotechs, and financial institutions to evaluate breakthrough medicines with unprecedented speed and rigor. By synthesizing complex clinical signals into actionable insights, Prudentia accelerates deal throughput and provides strategic leverage for acquisition, licensing, or investment decisions made by business development, investment, and diligence teams. The company’s human-in-the-loop approach orchestrates seamless collaboration between buyers, sellers, and intermediaries. This ensures a secure, compliant infrastructure

Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD7.1.2026 12:30:00 CET | Press release

FDA Accepts Investigational New Drug (IND) Application for COMP360 for the treatment of post-traumatic stress disorder (PTSD), enabling initiation of late-stage trialCompass continues to advance commercial preparations to be launch-ready by the end of the year for COMP360 for treatment-resistant depression (TRD)Management will host webinar with KOL and industry leaders to discuss PTSD clinical trial and commercial preparations for TRD from 10:00-11:30 am ET on January 7th Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for COMP360, enabling the initiation of a late-stage clinical trial in patients with PTSD. Compass management, along with KOL and industry leaders, will host a webinar today to discuss the company’s clinical trial plans for PTSD, as well as commercial preparations f

Stallergenes Greer Expands Venom Immunotherapy Production Capacity With Acquisition of Entomon s.r.l.7.1.2026 11:07:00 CET | Press release

Stallergenes Greer, a global leader in allergy therapeutics, today announced that it has entered into an agreement to acquire Entomon s.r.l., an Italian company specialising in the production of certified stinging-insect venom extracts, notably of the Hymenoptera order, used for the manufacture of diagnostic preparations and Venom Immunotherapy (VIT). The transaction is expected to close by the end of January. Entomon, currently recognised as the only company in Europe capable of extracting pure venom from Hymenoptera insects, produces pharmaceutical-grade insect venom using proprietary techniques (Entomon Capillary Extracted Venom®) for medical use. Through this acquisition, Stallergenes Greer bolsters its venom manufacturing capabilities and supply of raw materials for life-saving VIT treatments, whilst safeguarding patient care continuity. Hymenoptera venom allergy is the most common trigger of severe anaphylaxis in adults1. According to the EAACI guidelines on venom immunotherapy,

ARIS Announces New CEO to Lead Agentic AI-led Strategy7.1.2026 10:00:00 CET | Press release

CEO Appointment ARIS, a global leader in process intelligence and transformation software, today announced the appointment of Guillaume Bacuvier as Chief Executive Officer. Guillaume will lead ARIS through its next phase of growth as a fully standalone company, accelerating its evolution from a market leader in Process Intelligence into a foundational platform for enterprises deploying and governing Agentic AI. Guillaume brings deep international leadership experience across technology, data, and software-enabled businesses, with a proven track record of scaling global platforms and leading complex organisations. After starting as a strategic consultant at Booz Allen Hamilton, Guillaume spent over a decade at Google, rising to Vice President in EMEA where he built and scaled some of Google’s largest data-driven businesses in Europe and held P&L responsibility across multiple countries. In the last decade, Guillaume has served as CEO of multi-continent, data-centric companies including

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye